A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
Conditions: T Cells; Colorectal Cancer; Lynch Syndrome Interventions: Drug: Naproxen; Drug: Aspirin Sponsors: M.D. Anderson Cancer Center; National Institutes of Health (NIH); National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Aleve | Aspirin | Cancer | Cancer & Oncology | Clinical Trials | HNPCC | Lynch Syndrome | Naproxen | Research